r-sk与UK在治疗高血压脑出血术后局部应用的疗效评价  

Comparative Study of Recombinant Streptokinase and Urokinase to Treat Hypertensive Intracerebral Hemorrhage

作　　者：徐福林[1] 王建清[1] 宋爱芳[1] 贾丕丰[2] 吴劲松[2] 

机构地区：[1]上海瑞金医院集团闵行医院神经外科,上海201100 [2]复旦大学附属华山医院神经外科,上海200040

出　　处：《医学临床研究》2005年第4期443-445,共3页Journal of Clinical Research

基　　金：上海市闵行区科技发展基金项目(编号: 2001 51)

摘　　要：【目的】比较重组链激酶(r- sk)、尿激酶(UK)在治疗高血压脑出血术后的疗效。【方法】通过随机分组前瞻性研究比较两者的近期、远期的疗效。【结果】r- sk组与UK组相比两者术后疗效有明显差别。同时在术后神经功能恢复方面也有明显差别。【结论】r -sk能更好地溶解、引流脑内血肿,提高疗效,改善预后。To compare the effect of recombinant streptokinase and urokinase in the treatment of hypertensive intracerebral hemorrhage.A prospective comparative study was made between two groups about their short and long-term effect.There was significant difference between two groups in postoperative curative effect and the recovery of nerve function.[Conclusion]The recombinant streptokinase can better dissolve intracerebral hematoma,improve the curative effect and meliorate prognosis.

关 键 词：高血压/并发症 脑出血/外科学 链激酶/治疗应用 尿激酶/治疗应用 

分 类 号：R544.1[医药卫生—心血管疾病]